Smith Graham & Co. Investment Advisors LP trimmed its holdings in shares of Veradigm Inc. (NASDAQ:MDRX - Free Report) by 33.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 352,062 shares of the software maker's stock after selling 173,853 shares during the period. Smith Graham & Co. Investment Advisors LP owned about 0.32% of Veradigm worth $3,693,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Quarry LP purchased a new stake in shares of Veradigm during the first quarter valued at approximately $37,000. Tower Research Capital LLC TRC raised its stake in shares of Veradigm by 95.0% during the second quarter. Tower Research Capital LLC TRC now owns 5,310 shares of the software maker's stock valued at $67,000 after purchasing an additional 2,587 shares during the period. Envestnet Asset Management Inc. raised its stake in shares of Veradigm by 27.4% during the first quarter. Envestnet Asset Management Inc. now owns 32,691 shares of the software maker's stock valued at $69,000 after purchasing an additional 7,027 shares during the period. Advisor Group Holdings Inc. raised its stake in shares of Veradigm by 15.6% during the fourth quarter. Advisor Group Holdings Inc. now owns 4,833 shares of the software maker's stock valued at $85,000 after purchasing an additional 651 shares during the period. Finally, Osaic Holdings Inc. raised its stake in shares of Veradigm by 72.4% during the second quarter. Osaic Holdings Inc. now owns 6,825 shares of the software maker's stock valued at $86,000 after purchasing an additional 2,866 shares during the period.
Analyst Ratings Changes
A number of analysts have recently issued reports on the stock. StockNews.com assumed coverage on shares of Veradigm in a research note on Sunday, April 7th. They set a "hold" rating on the stock. Deutsche Bank Aktiengesellschaft restated a "hold" rating and issued a $10.00 price target (down previously from $15.00) on shares of Veradigm in a research note on Tuesday, March 19th. Royal Bank of Canada dropped their price target on shares of Veradigm from $22.00 to $11.00 and set an "outperform" rating for the company in a research note on Friday, January 19th. Finally, Barclays assumed coverage on shares of Veradigm in a research note on Wednesday, January 3rd. They issued an "equal weight" rating and a $11.00 price target for the company. Five investment analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $11.25.
Check Out Our Latest Stock Analysis on Veradigm
Veradigm Stock Performance
Veradigm stock traded down $0.10 during mid-day trading on Friday, reaching $7.70. The company's stock had a trading volume of 231,597 shares, compared to its average volume of 1,095,184. The business has a 50 day moving average price of $7.91 and a 200-day moving average price of $10.31. Veradigm Inc. has a twelve month low of $5.01 and a twelve month high of $14.09.
About Veradigm
(
Free Report)
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Read More
Before you consider Veradigm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.
While Veradigm currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
